Gene · 4303
Papers2,706
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,706
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| First Radiologic Description of CIC-FOXO4 Sarcoma: A Case Report of a Rare and Aggressive Sarcoma and Review of the Literature. | Cureus | 2025 | 41426942 | PubTator, text mining | PubMed |
| Recognition of two hydrophobic pockets in the KIX domain of CBP by FOXO4 transactivation domain. | Commun Biol | 2025 | 41381850 | PubTator, text mining | PubMed |
| Effect of PEDV infection on IPEC-J2 cells on miR-328-3p/FoxO4/NF-κB/MLCK signaling axis. | Vet Microbiol | 2025 | 41135376 | PubTator, text mining | PubMed |
| HPV as a Molecular Hacker: Computational Exploration of HPV-Driven Changes in Host Regulatory Networks. | Viruses | 2025 | 41012596 | PubTator, text mining | PubMed |
| Advantages and Possibility of Transcription Factors FOXOs in HCC. | Cell Biochem Funct | 2025 | 41002121 | PubTator, text mining | PubMed |
| Targeting the Wnt/β-catenin pathway and epithelial-mesenchymal transition in gastric cancer: mechanisms, therapeutic strategies, and clinical challenges. | Front Oncol | 2025 | 40951343 | PubTator, text mining | PubMed |
| Regulatory mechanisms of Th9 cell differentiation. | Front Immunol | 2025 | 40948790 | PubTator, text mining | PubMed |
| Matrine alleviates the immune imbalance of atopic dermatitis by up-regulating FOXO4 to inactivate circTNFRSF21-mediated JAK/STAT3 axis. | Immunopharmacol Immunotoxicol | 2025 | 40926524 | PubTator, text mining | PubMed |
| Combinatorial targeting of PI3K/AKT pathway with BKM120 increases cisplatin sensitivity and apoptotic response in A549 lung cancer cells. | Cell Mol Biol (Noisy-le-grand) | 2025 | 40920328 | PubTator, text mining | PubMed |
| Diagnostic value of Ep300 and FOXO4 proteins in acute ischemic stroke: preliminary findings from a case-control study. | PeerJ | 2025 | 40900757 | PubTator, text mining | PubMed |
| FOXO4-AR crosstalk in PCOS: A pivotal mechanism of anovulation. | Mol Ther Nucleic Acids | 2025 | 40896589 | PubTator, text mining | PubMed |
| Ubiquitinome profiling identifies USP13-CMAS axis as critical regulator of hair follicular melanogenesis via K48-linked polyubiquitination. | Cell Signal | 2025 | 40876694 | PubTator, text mining | PubMed |
| The multifaceted impact of physical exercise on FoxO signaling pathways. | Front Cell Dev Biol | 2025 | 40861274 | PubTator, text mining | PubMed |
| A multilevel genomic approach to uncover causal connections between CPFE and lung cancer subtypes: A two-sample Mendelian randomization study. | Medicine (Baltimore) | 2025 | 40859573 | PubTator, text mining | PubMed |
| Metabolic dysregulation in pulmonary fibrosis: insights into amino acid contributions and therapeutic potential. | Cell Death Discov | 2025 | 40858556 | PubTator, text mining | PubMed |
| Machine learning-driven multi-targeted drug discovery in colon cancer using biomarker signatures. | NPJ Precis Oncol | 2025 | 40847045 | PubTator, text mining | PubMed |
| Developing the risk prediction model (ProlncSig) from lipoxygenase pathway-related lncRNAs for prognosis prediction in breast cancer. | RNA Biol | 2025 | 40820368 | PubTator, text mining | PubMed |
| Persistent accumulation of therapy-induced senescent cells: an obstacle to long-term cancer treatment efficacy. | Int J Oral Sci | 2025 | 40750580 | PubTator, text mining | PubMed |
| Placental Transcriptomic Analysis in Retinopathy of Prematurity Reactivation After Anti-VEGF Treatment. | Am J Ophthalmol | 2025 | 40749864 | PubTator, text mining | PubMed |
| Progress of targeted FOX family therapy in ovarian cancer. | Front Pharmacol | 2025 | 40746724 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4303/papers?page=3